FindTrial
Sign In

Study to see the outcome of intravenous phosphate supplementation in live liver donors

Randomized controlled trial to study the outcome of intravenous phosphate supplementation in live donors undergoing hepatectomy for Living Donor Liver Transplantation (LDLT)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/016914
Enrollment
140
Registered
2019-01-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: potassium phosphate injection: The preparation is given slowly, intravenously over 4 hours diluted in 500 ml normal saline. One ml of the preparation contains 3 mmol of phosphorous whic

Sponsors

Institute of Liver Biliary Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All donors evaluated as per institutional protocol for donor hepatectomy and found fit Those who consent.

Exclusion criteria

Exclusion criteria: Patients refusing to consent for inclusion in the study. Minor hepatectomy Those who develop profound hypophosphatemia in the control group

Design outcomes

Primary

MeasureTime frame
To study the outcome of phosphate supplementation in reducing the occurrence of postoperative complicationsTimepoint: till discharge—

Secondary

MeasureTime frame
Duration of hospital stayTimepoint: Till discharge;Duration of ICU stayTimepoint: Till discharge;To analyze the role of phosphate supplementation in liver regenerationTimepoint: Till discharge;To study the correlation between phosphate levels and trend in post-operative LFTsTimepoint: Till discharge;To study the serum phosphate levels and its trend post operativelyTimepoint: Till discharge—

Countries

India

Contacts

Public ContactDr Viniyendra Pamecha

ILBS, New Delhi

viniyendra@yahoo.co.uk

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026